SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-038529
Filing Date
2023-05-11
Accepted
2023-05-11 16:05:58
Documents
89
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_immucell.htm   iXBRL 10-Q 1348589
2 CERTIFICATION f10q0323ex31_immucell.htm EX-31 9525
3 CERTIFICATION f10q0323ex32_immucell.htm EX-32 4451
  Complete submission text file 0001213900-23-038529.txt   7864018

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE iccc-20230331.xsd EX-101.SCH 85880
5 XBRL CALCULATION FILE iccc-20230331_cal.xml EX-101.CAL 36985
6 XBRL DEFINITION FILE iccc-20230331_def.xml EX-101.DEF 296980
7 XBRL LABEL FILE iccc-20230331_lab.xml EX-101.LAB 614059
8 XBRL PRESENTATION FILE iccc-20230331_pre.xml EX-101.PRE 319725
83 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_immucell_htm.xml XML 1454115
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 23910930
SIC: 2835 In Vitro & In Vivo Diagnostic Substances